Study of Pediatric Migraine: The Pediatric Migraine Registry
NCT03742024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201
Last updated 2021-04-13
Summary
This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.
Conditions
Sponsors & Collaborators
-
University of California, San Francisco
collaborator OTHER - lead OTHER
Principal Investigators
-
Christoph Hornik, MD · Duke University
-
Amy Gelfand, MD · University of California at San Francisco
Eligibility
- Min Age
- 4 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-05
- Primary Completion
- 2021-02-08
- Completion
- 2021-02-08
Countries
- United States
Study Locations
More Related Trials
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
NCT05711394 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
NCT04530110 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
NCT04418765 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
NCT04464707 ·Status: COMPLETED ·Phase: PHASE3
-
AMG 334 20160172 Pediatric Migraine PK Study.
NCT03499119 ·Status: COMPLETED ·Phase: PHASE1
-
Patent Foramen Ovale in Children With Migraine Headaches
NCT00750594 ·Status: COMPLETED
-
Eptinezumab in Participants With Episodic Cluster Headache
NCT04688775 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine
NCT01905748 ·Status: UNKNOWN ·Phase: NA
-
A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
NCT04537429 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine
NCT03400059 ·Status: COMPLETED ·Phase: NA
-
A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
NCT05102591 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
NCT05127954 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
NCT00158002 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
NCT03238781 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
NCT04458857 ·Status: COMPLETED ·Phase: PHASE3
-
Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients
NCT04466826 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
NCT04743141 ·Status: RECRUITING ·Phase: PHASE3
-
A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks
NCT03159000 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Incidents of Weekend Headaches in Children
NCT05218330 ·Status: UNKNOWN
-
Peripheral Nerve Stimulation Registry for Intractable Migraine Headache
NCT02227758 ·Status: COMPLETED
-
Melatonin for Adolescent Migraine Prevention Study
NCT03150797 ·Status: TERMINATED ·Phase: PHASE2
-
Eptinezumab in Adults With Migraine and Medication Overuse Headache
NCT04772742 ·Status: COMPLETED ·Phase: PHASE3
-
The Childhood and Adolescent Migraine Prevention Study
NCT01581281 ·Status: TERMINATED ·Phase: PHASE3
-
Real World Effectiveness of Eptinezumab in Participants With Migraine
NCT05284019 ·Status: TERMINATED ·Phase: PHASE4